A simple test saves lives. Three out of four women who died of cervical cancer in the screening age of 25-69 years had not had a Pap smear in the past three and a half years.
Lung cancer is one of the most dangerous forms of cancer. Treatments are available, but they are demanding on patients and less than 30 percent survive. But mRNA technology is offering new hope for higher survival rates because treatments target the malignant cells in an entirely new way.
Researchers are on the trail of a new method to protect against heart damage after cancer treatment.
Even the toughest “soldiers” in our immune system are not tenacious enough to knock out cancerous tumours. NTNU professor Øyvind Halaas aims to do something about that.
Certain type of cancer drugs that promote the death of cells can actually be harmful if combined with other treatments that damage our DNA, RNA or proteins, researchers have found.
A treatment that kills the cancer cells in one fell swoop, without causing the patient to feel sick from the medication’s side effects? That’s the goal of new personalized cancer therapies that are being developed across the globe, including at NTNU.
Many patients are treated for prostate cancer unnecessarily. Norwegian researchers are working to reduce overtreatment, while at the same time detecting the sickest patients. Now they’re receiving EU support.
A new approach to cancer treatment combines ultrasound, bubbles and nanoparticles with chemotherapy. In an experiment, the treatment has cured cancer in mice.
A new method for targeted delivery of cancer drugs in the body produces startling results. The method may soon be available for human use.
Silver is often used as a coating on medical equipment used for chemotherapy. The problem is that this silver coating can break down drugs. Now, researchers have found a graphene coating that will help boost the effect of chemotherapy.